IVRO (Invitro International) FCF Margin %: -5.31% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Invitro International FCF Margin %?

Invitro International IVRO +1.33% FCF Margin % is -5.31% as of Mar. 2026. The stock has 1 warning sign investors should review. Among 203 Medical Diagnostics & Research companies, Invitro International ranks better than 54.19% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Invitro International's Free Cash Flow for the three months ended in Mar. 2026 was $-0.01 Mil. Invitro International's Revenue for the three months ended in Mar. 2026 was $0.21 Mil. Therefore, Invitro International's FCF Margin % for the quarter that ended in Mar. 2026 was -5.31%.

As of today, Invitro International's current FCF Yield % is 0.93%.

The historical rank and industry rank for Invitro International's FCF Margin % or its related term are showing as below:

IVRO' s FCF Margin % Range Over the Past 10 Years
Min: -314.29   Med: -188.24   Max: 12.21
Current: 1.69

During the past 9 years, the highest FCF Margin % of Invitro International was 12.21%. The lowest was -314.29%. And the median was -188.24%.

IVRO's FCF Margin % is ranked better than
54.19% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.96 vs IVRO: 1.69

Invitro International FCF Margin % Related Terms

Invitro International FCF Margin % Historical Data

* Premium members only.

The historical data trend for Invitro International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International FCF Margin % Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96 Sep24 Sep25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only -188.24 -254.55 -172.73 12.21 -0.91

Invitro International Quarterly Data
Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.64 7.69 -0.49 4.37 -5.31

IVRO vs IDTA, PRPH, NSTM: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Invitro International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invitro International FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Invitro International's FCF Margin % falls into.


Invitro International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Invitro International's FCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-0.008/0.879
=-0.91 %

Invitro International's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.011/0.207
=-5.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -5.31% mean?
Invitro International (IVRO) has a FCF Margin % of -5.31% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Invitro International and its competitors. According to the industry distribution chart, Invitro International ranks #93 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 45.8%.
Is Invitro International's FCF Margin % too high?
Invitro International's current FCF Margin % is -5.31%. Based on the distribution chart, Invitro International ranks #93 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Invitro International's FCF Margin % compare to IDTA and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #93 out of 203 companies for FCF Margin %. This puts Invitro International in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Invitro International and its competitors. Invitro International's current FCF Margin % is -5.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.07 — trading 35.8% above its estimated fair value. The current FCF Margin % is -5.31%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Invitro International (IVRO), the current FCF Margin % is -5.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Invitro International Business Description

Address 330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.